Peri-procedural treatment with high dose Rosuvastatin reduces soluble TNF receptor 1 in patients treated with primary percutaneous coronary intervention for ST elevation myocardial infarction
31 August 2019 (11:00 - 16:00)
Organised by:
Abstract
About the speaker
Stavanger University Hospital, Stavanger (Norway)
16 More presentations in this session
Access the full session
The Event
ESC Congress 2019
31 August 2019
11:00 CET
